Every industry is being transformed by data. Finance, retail, manufacturing, logistics all have internal intelligence systems that guide strategy and operations. Healthcare has enormous data. The industry generates millions of claims annually, each one packed with information about what people are sick with, what they’re being treated for, whether that treatment works, and what it costs. But the employer paying for most of it usually sees almost none of that data.
In a fully insured arrangement, your carrier controls your claims data. You get an annual renewal rating sheet that shows aggregate utilization and trend. You see medical and pharmacy cost breakdowns. You might get a comparison to industry benchmarks. That’s it. The granular detail, specific conditions, medications, procedures, providers, cost outliers, stays with the carrier.
Why carriers cite HIPAA and why that argument is weak
The carrier’s standard explanation is HIPAA. They can’t share identifiable data, and generalized data is proprietary. But this is a weak argument. Researchers share healthcare data all the time while maintaining privacy. Universities, NIH, and research institutions have been anonymizing healthcare datasets for decades. The technical barriers are minimal. The legal barriers are mostly constructed.
What actually happens is information asymmetry. You can’t see cost drivers, so you can’t question the premium or negotiate from knowledge. You can’t identify the conditions creating the most claims for your population. You can’t see whether your claims are unusually bad or whether you’re being compared against a favorable reference group. The carrier has all the information, and you’re working in the dark.
That asymmetry benefits the carrier in tangible ways. They can rate aggressively because you lack the data to push back. They can use benchmark comparisons that make your experience look worse than it is. They can shift the structure of a cost increase without it being obvious in your summary sheet.
What self-funding changes
Self-funding changes this dynamic. When you self-fund, you own the claims data. You can see the actual experience of your population: what conditions are driving spend, which members are high-cost, what procedures are being used, which providers are expensive relative to outcomes. You get detailed TPA reports and access to analytics platforms. You can actually understand your population’s health and cost profile.
A group captive adds another layer. You get your own claims data, plus pool-level data. You can see how your experience compares to similar employers in the same pool. You can identify whether your high-cost drivers are unique to your company or common across the pool. You can evaluate whether your claims trends are within expected variance or whether something structural is shifting.
That transparency enables better decisions. You might discover that your pharmacy spend is 20 percent higher than pool average and invest in specialty medication management. You might find that orthopedic procedures are your largest category and negotiate better rates with high-volume providers. You might identify a high-cost chronic condition and implement a targeted wellness program. None of that is possible when you’re working from a carrier-provided summary.
The financial case
The risk-reward ratio on self-funding is often cited as roughly four to one. You take on more engagement and more operational involvement. In return, the potential upside from better cost management, vendor accountability, and member engagement typically returns four dollars for every dollar invested in the work. That’s not guaranteed. It depends on execution. But the visibility itself changes what’s possible.
The question isn’t whether self-funding is better than fully insured in the abstract. For most mid-market companies with stable populations, the data suggests it is. The question is whether your leadership team is ready to own that data, invest in understanding it, and use it to drive decisions. If the answer is yes, the case for self-funding or a captive is strong. If the answer is not yet, fully insured probably remains the right choice until the organization is ready to engage with the economics.
If you want to understand what your claims data would actually look like in a self-funded arrangement, reach out for an independent eligibility review.
Leave a Reply